Ascent Pharmaceuticals, Inc.

Ascent Pharmaceuticals, Inc. (United States) has no DMF, CEP or site registration linked in our records. 7 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Ascent Pharmaceuticals, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/ascent-pharmaceuticals-inc

Overview

Ascent Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Central Islip, United States.

FDA compliance signals

7 FDA enforcement records linked to this company.

  • 4832022-09-15

    Failure to comply with REMS Implementation System

  • recall — Class II2021-12-15

    Product Mix-up

  • recall — Class II2020-11-25

    Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.

  • recall — Class III2018-02-07

    Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol

  • 4832012-12-06

    Following/documenting laboratory controls

  • 4832012-12-06

    Washing and toilet facilities are deficient

  • 4832012-12-06

    Samples (various types) representative, identified properly

For suppliers

Is this Ascent Pharmaceuticals, Inc.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.